This document discusses the history and current state of pharmacovigilance in India and internationally. It describes key events in pharmacovigilance including the establishment of drug safety monitoring committees in the UK and US in the 1960s, the creation of the yellow card system in the UK, and the founding of the Uppsala Monitoring Centre by the WHO in 1968. It outlines India's contribution to the WHO pharmacovigilance program, noting that India was the 7th highest contributor of safety reports to the global database in 2013. The document also provides guidance on what types of adverse drug reactions should be reported in India.